FDA.reportPublic FDA data

pemigatinib 13.5 MG Oral Tablet

RxCUI
2359334
RxNorm name
pemigatinib 13.5 MG Oral Tablet
Display name
pemigatinib 13.5 MG Oral Tablet
Full name
pemigatinib 13.5 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9e1f2222-1d89-4e63-989c-ccebe2ab1eb4pemigatinib 13.5 MG Oral TabletPSN15These highlights do not include all the information needed to use PEMAZYRE safely and effectively. See full prescribing information for PEMAZYRE . PEMAZYRE® (pemigatinib) tablets, for oral use Initial U.S. Approval: 202020230614
9e1f2222-1d89-4e63-989c-ccebe2ab1eb4pemigatinib 13.5 MG Oral TabletSCD15These highlights do not include all the information needed to use PEMAZYRE safely and effectively. See full prescribing information for PEMAZYRE . PEMAZYRE® (pemigatinib) tablets, for oral use Initial U.S. Approval: 202020230614